Marker Therapeutics Inc (MRKR)

[Phantom Lord]

That's always my biggest question also. I don't want to be diluted to hell. Every time I bring it up I get the same answer which is the company fully believes they can make it to the end of 2025 with what they have. I was originally skeptical that they could make it that far but the 10Qs do seem to back them up as they have got their spending in check.

There is a 99% chance we experience some dilution but I previously spoke to Vera about this and he said it would be done on the back of a news release. My guess would be the final lymphoma data which shouldn't be too long. IMO, early next year at the latest but we'll see when we get the enrollment update.

If the results there are not enough to gain som major SP appreciation then the dilution will be the least of our worries.